Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial von Bays, Harold, Gaudet, Daniel, Weiss, Robert, Ruiz, Juan Lima, Watts, Gerald F, Gouni-Berthold, Ioanna, Robinson, Jennifer, Zhao, Jian, Hanotin, Corinne, Donahue, Stephen

Volltext

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II rand... von Farnier, Michel, Jones, Peter, Severance, Randall, Averna, Maurizio, Steinhagen-Thiessen, Elisabeth, Colhoun, Helen M, Du, Yunling, Hanotin, Corinne, Donahue, Stephen

Volltext

The prevalence of low muscle mass associated with obesity in the USA von Murdock, Dana J, Wu, Ning, Grimsby, Joseph S, Calle, Roberto A, Donahue, Stephen, Glass, David J, Sleeman, Mark W, Sanchez, Robert J

Volltext

Multifocal motor neuropathy: 30 years from onset to diagnosis von Hobson-Webb, Lisa D., Donahue, Stephen N., Bey, Richard D.

Volltext

Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice von Byrnes, John J., Gross, Stefan, Ellard, Courtney, Connolly, Kelly, Donahue, Stephen, Picarella, Dominic

Volltext

A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness von Bjornsson, Thorir D., Wagner, John A., Donahue, Stephen R., Harper, Dawn, Karim, Aziz, Khouri, Marlene S., Murphy, William R., Roman, Kristin, Schneck, Dennis, Sonnichsen, Daryl S., Stalker, Dennis J., Wise, Stephen D., Dombey, Stuart, Loew, Caroline

Volltext

The Fifth Vital Sign-What Does It Mean? von Walid, Mohammad Sami, Donahue, Stephen N., Darmohray, Dana M., Hyer Jr, Leon A., Robinson Jr, Joe Sam

Volltext

Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia The ODYSSEY HoFH Trial von Blom, Dirk J., Harada-Shiba, Mariko, Rubba, Paolo, Gaudet, Daniel, Kastelein, John J. P., Charng, Min-Ji, Pordy, Robert, Donahue, Stephen, Ali, Shazia, Dong, Yuping, Khilla, Nagwa, Banerjee, Poulabi, Baccara-Dinet, Marie, Rosenson, Robert S.

Volltext

Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipo... von Krempf, Michel, Hopkins, Paul N, Bruckert, Eric, Lee, Shane, Donahue, Stephen

Volltext

Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder : Results of a Double-Blind, Placebo-Co... von RICKELS, Karl, MATHEW, Sanjay, BANOV, Michael D, ZIMBROFF, Daniel L, OSHANA, Scott, PARSONS, Edward C, DONAHUE, Stephen R, KAUFFMAN, Michael, IYER, Ganesh R, REINHARD, John F

Volltext

1200-P: The Prevalence of Obesity-Associated Loss of Lean Muscle Mass von MURDOCK, DANA J., WU, NING, GLASS, DAVID J., GRIMSBY, JOSEPH S., CALLE, ROBERTO A., DONAHUE, STEPHEN, SLEEMAN, MARK, SANCHEZ, ROBERT J.

Volltext

Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19 von Donahue, Stephen R., Flockhart, David A., Abernethy, Darrell R., Ko, Jae‐Wook

Volltext

Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: A 28-day, open-label study von Mathew, Sanjay J., MD, Garakani, Amir, MD, Reinhard, Jr, John F., PhD, Oshana, Scott, BS, Donahue, Stephen, MD

Volltext

Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes von DONAHUE, Stephen R, TURNER, Kenneth C, PATEL, Shardul

Volltext

Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia von Blom, Dirk J., Harada-Shiba, Mariko, Rubba, Paolo, Gaudet, Daniel, Kastelein, John J.P., Charng, Min-Ji, Pordy, Robert, Donahue, Stephen, Ali, Shazia, Dong, Yuping, Khilla, Nagwa, Banerjee, Poulabi, Baccara-Dinet, Marie, Rosenson, Robert S.

Volltext

Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-fu... von Hopkins, Paul, Krempf, Michel, Bruckert, Eric, Donahue, Stephen, Yang, Feng, Zhang, Yi, Dicioccio, A. Thomas

Volltext

A Twofold Approach: Integrating Simulation and Risk Management Training [26D] von Ecker, Elizabeth, Moller, Jennifer, Lagnese, Joyce, Donahue, Stephen, Nowicki, Thomas, Marchegiani, Heather

Volltext

Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-fu... von Hopkins, Paul N., Krempf, Michel, Bruckert, Eric, Donahue, Stephen, Yang, Feng, Zhang, Yi, DiCioccio, A. Thomas

Volltext

Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosu... von Robinson, Jennifer G., Colhoun, Helen M., Bays, Harold E., Jones, Peter H., Du, Yunling, Hanotin, Corinne, Donahue, Stephen

Volltext

Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial von Moriarty, Patrick M., Thompson, Paul D., Cannon, Christopher P., Guyton, John R., Bergeron, Jean, Zieve, Franklin J., Bruckert, Eric, Jacobson, Terry A., Baccara-Dinet, Marie T., Zhao, Jian, Donahue, Stephen, Ali, Shazia, Manvelian, Garen, Pordy, Robert

Volltext